- Home
- MSPR vs ADXN Comparison
MSPR vs ADXN Comparison
Compare MSPR & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSPR
- ADXN
- Stock Information
- Founded
- MSPR 2014
- ADXN 2002
- Country
- MSPR United States
- ADXN Switzerland
- Employees
- MSPR N/A
- ADXN N/A
- Industry
- MSPR
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- MSPR
- ADXN Health Care
- Exchange
- MSPR NYSE
- ADXN Nasdaq
- Market Cap
- MSPR 7.8M
- ADXN 8.1M
- IPO Year
- MSPR N/A
- ADXN N/A
- Fundamental
- Price
- MSPR $1.23
- ADXN $9.00
- Analyst Decision
- MSPR
- ADXN Strong Buy
- Analyst Count
- MSPR 0
- ADXN 1
- Target Price
- MSPR N/A
- ADXN $30.00
- AVG Volume (30 Days)
- MSPR 47.6K
- ADXN 7.6K
- Earning Date
- MSPR 08-13-2025
- ADXN 06-19-2025
- Dividend Yield
- MSPR N/A
- ADXN N/A
- EPS Growth
- MSPR N/A
- ADXN N/A
- EPS
- MSPR N/A
- ADXN 0.10
- Revenue
- MSPR $13,085,000.00
- ADXN $278,508.00
- Revenue This Year
- MSPR N/A
- ADXN $86.57
- Revenue Next Year
- MSPR N/A
- ADXN N/A
- P/E Ratio
- MSPR N/A
- ADXN $0.74
- Revenue Growth
- MSPR 34.74
- ADXN N/A
- 52 Week Low
- MSPR $1.10
- ADXN $6.51
- 52 Week High
- MSPR $13.50
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- MSPR N/A
- ADXN 55.39
- Support Level
- MSPR N/A
- ADXN $8.02
- Resistance Level
- MSPR N/A
- ADXN $9.78
- Average True Range (ATR)
- MSPR 0.00
- ADXN 0.73
- MACD
- MSPR 0.00
- ADXN 0.02
- Stochastic Oscillator
- MSPR 0.00
- ADXN 32.94
About MSPR MSP RECOVERY INC
MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.